Navigation Links
Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
Date:9/9/2009

CLEVELAND, Ohio and DENVER, Colorado, September 9 /PRNewswire/ -- Simbionix USA Corporation, a global leader in simulation and training products for clinical professionals, today announced the appointment of Mr. Paul Jensen as the new General Manager for Simbionix's eLearning and Content business.

Mr. Jensen is an information services executive with extensive experience in building innovative information products and services for a variety of professional markets including education and corporate training. He was responsible for the learning management system for Aplia, a leading Web-based homework solution for higher education, and he created the first eLearning product strategy for Thomson Learning. Most recently, Mr. Jensen held several senior management roles with Wolters Kluwer, a global leader in information services and publishing, including responsibility for enterprise-wide strategies and business priorities for online content delivery systems. He earned his MBA, with honors, from Columbia Business School.

"Over the previous four months we were involved in an intensive, nationwide recruitment process to find the ideal person to lead our growing eLearning and Content business, and we are very pleased to have Paul join Simbionix," said Gary Zamler, Simbionix's CEO. "In order to meet the growing training and performance improvement needs of our global customers, Simbionix now offers a full range of integrated training solutions including virtual reality simulations, online courseware and learning management systems under our MentorLearn(TM) umbrella of products and services. Paul's talent, proven leadership, experience in identifying global trends and commercializing new e-Learning products and services, as well as in the delivery of online content, will be another building block in Simbionix's exponential growth and success in these areas of the global training and performance improvement market."

About Simbionix USA Corporation

Simbionix is the leader in the development and delivery of innovative and effective virtual reality simulation products and solutions for clinical education and training of medical professionals. The products are designed to accelerate best-practice medical training, advance clinical performance, and improve patient safety.

The Simbionix product line includes the ANGIO Mentor(TM) line for endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and the URO Mentor(TM) for urological procedures. In addition, Simbionix distributes the HystSim(TM) for hysteroscopic procedures. Each simulation platform is a leading simulator in the relevant clinical area.

Simbionix simulation products have been validated in several scientific studies and the company cooperates closely with both industry and leading medical institutions to develop the most advanced simulators for the training and assessment of medical professionals.

    Contact:
    Gary Zamler
    CEO
    Simbionix
    Tel: +1-216-229-2040
    gary@simbionix.com



'/>"/>
SOURCE Simbionix
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
2. Simbionix Increases Product Offerings for OB/GYN Physicians
3. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
4. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
5. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
6. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
7. Simbionix Launches Innovative Patient-Specific Simulation
8. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
9. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
10. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
11. eBioscience Corporation Acquires NatuTec GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... PA (PRWEB) , ... April 18, 2017 , ... ... to Halo Labs . The move comes after the company changed focus ... new market, our new brand and our new technology,” says CEO Robert Hart. ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of ... accessible to novices as well as experienced users, attendees will gain a better ... screening tests. , Hemostasis testing quality is determined by preanalytical variables which ...
(Date:4/19/2017)... 19, 2017 Veracyte, Inc. ... it will report its first quarter 2017 financial ... 2017. Following the announcement, Veracyte,s management will host a live ... discuss the company,s financial results and business progress. ... may be accessed by visiting Veracyte,s website at  http://investor.veracyte.com . ...
(Date:4/18/2017)... ... ... For a historic seventh consecutive year, Benchmark Research along with PMG Research ... of the top two Clinical Research Sites or Network. Benchmark Research has ... times previously, and first runner up the other three years. The only awards ceremony ...
Breaking Biology Technology:
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):